by Steve Schonberg | Dec 14, 2020 | Collaboration
Funding Awarded as Part of the Organization’s New $15 Million “Target ALS Diagnosis Initiative” Target ALS announced today the grantees receiving funding for new projects focused on ALS biomarker discovery and development, resulting from a call for proposals issued...
by Steve Schonberg | Dec 4, 2020 | Collaboration
We speak to Dr. Robert Miller, Ph.D. about the intricacies of distributing ALS research funding. Learn about the process. Nonprofits bear a heavy burden when distributing endowments and grants toward projects that advance their organization’s mission. As groups like...
by Target ALS | Jun 2, 2020 | Collaboration
As the world begins the restoration project that is life after COVID-19, a major challenge will be establishing means to carefully return to daily activities. For Ludo Van Den Bosch of the Belgium-based Flanders Institute for Biotechnology (VIB), that means proceeding...
by Steve Schonberg | May 5, 2020 | Collaboration
Today, Target ALS and The Association for Frontotemporal Degeneration (AFTD) announced $5 million in funding awards for work by six research teams to aid in the discovery of biomarkers and viable treatments for ALS and frontotemporal degeneration (FTD). ALS and FTD...
by Steve Schonberg | Mar 19, 2020 | Collaboration
Target ALS and The ALS Association recently announced a new partnership committed to the discovery of biomarkers for ALS. Structured as a precompetitive initiative between scientists in academia and the pharmaceutical/biotech industry, Target ALS and The ALS...
